Novel Pediatric Sepsis Criteria and Clinical Decision Support Tools

新型儿科败血症标准和临床决策支持工具

基本信息

  • 批准号:
    10684927
  • 负责人:
  • 金额:
    $ 63.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Pediatric sepsis is a major global public health problem associated with millions of deaths every year. However, the current criteria to diagnose pediatric sepsis are outdated, lack specificity, do not allow early detection and risk stratification in all settings, and are discordant with clinician-based diagnosis. In 2016, the adult Sepsis-3 task force redefined sepsis as “life-threatening organ dysfunction caused by a dysregulated host response to infection,” emphasizing the pivotal role of organ dysfunction in the pathophysiology of sepsis. Importantly, they used a data-driven approach. The adult Sepsis-3 criteria, however, have been criticized for their limited applicability outside the intensive care unit and in resource-limited settings. The pediatric criteria are still based on the systemic inflammatory response syndrome and unvalidated organ dysfunction criteria. In 2019, the Society of Critical Care Medicine and other major global organizations sponsored the creation of the Pediatric Sepsis Definition Task Force to update the definition and operational criteria for pediatric sepsis. The overall objective of this proposal is to derive and validate novel pediatric sepsis criteria that generalize beyond the ICU and to differently resourced settings. The new criteria will be based on measures of organ dysfunction. However, it remains unknown which organ dysfunction measures are optimal for the new pediatric sepsis criteria. Furthermore, there is currently no pediatric emergency and inpatient database with the granularity and broad representation needed to derive and validate the new sepsis criteria. In this proposal, we will address these critical gaps to advance the science and clinical care of pediatric sepsis. We will extend our prior work and leverage the expertise of our international investigative team to build a large, centralized electronic health record database of pediatric emergency and inpatient care from institutions in both high-income countries and low- and middle-income countries. We will use these rich clinical data to accomplish the following aims: 1) determine the optimal clinical criteria for each pediatric organ dysfunction in differently resourced settings and care environments, 2) develop and validate novel pediatric sepsis criteria, and 3) design, build, and evaluate prototype CDS tools to facilitate use of the new pediatric sepsis criteria. We have assembled an investigative team with a successful track record in the field and will work in partnership with the Pediatric Sepsis Definition Task Force to address this global health priority. We expect the results of this proposal to have a powerful and sustained impact on the science of pediatric sepsis and organ dysfunction and ultimately improve sepsis recognition, accelerate appropriate effective treatment, decrease unnecessary treatment, and improve the outcomes of children with sepsis around the world.
项目摘要/摘要 小儿脓毒症是每年数百万死亡的主要全球公共卫生问题。然而, 诊断儿科败血症的当前标准已过时,缺乏特异性,不允许早期检测和 在所有情况下的风险分层,并且与基于临床的诊断不一致。 2016年,成人Sepsis-3 工作队重新定义败血症为“威胁生命的器官功能障碍,由宿主对宿主反应失调引起 感染,“强调器官功能障碍在败血症的病理生理学中的关键作用。重要的是,它们 使用了数据驱动的方法。但是,成人Sepsis-3标准对于有限的 重症监护室外和资源有限设置之外的适用性。小儿标准仍然基于 关于系统性炎症反应综合征和未验证器官功能障碍标准。 2019年 重症监护医学学会和其他主要全球组织赞助了小儿的创建 败血症定义工作组更新小儿脓毒症的定义和操作标准。总体 该提议的目的是得出并验证新型的小儿脓毒症标准,该标准概括了 ICU和不同采购的设置。新标准将基于器官的度量 功能障碍。但是,尚不清楚哪种器官功能障碍措施最适合新的儿科 败血症标准。此外,目前没有儿科紧急和住院数据库 粒度和广泛的表示,以得出和验证新的败血症标准。在这个建议中,我们 将解决这些关键差距,以促进小儿败血症的科学和临床护理。我们将扩展我们的 先前的工作并利用我们国际调查团队的专业知识来建立一个大型的集中式 来自两者的机构的小儿紧急和住院护理的电子健康记录数据库 高收入国家和低收入和中等收入国家。我们将使用这些丰富的临床数据来完成 以下目的:1)确定每个小儿器官功能障碍的最佳临床标准 资源丰富的设置和护理环境,2)开发和验证新型的小儿脓毒症标准,3)设计, 构建并评估原型CDS工具,以促进新的儿科败血症标准的使用。我们已经组装了 一个调查团队在该领域取得了成功的记录,并将与小儿合作合作 败血症定义工作队以解决这一全球健康优先级。我们希望该提议的结果能 对小儿败血症和器官功能障碍的科学的强大而持续的影响,最终 改善脓毒症的识别,加速适当的有效治疗,减少不必要的治疗以及 改善世界各地败血症儿童的结果。

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Derivation, validation, and transcriptomic assessment of pediatric septic shock phenotypes identified through latent profile analyses: Results from a prospective multi-center observational cohort.
通过潜在特征分析确定的儿科感染性休克表型的推导、验证和转录组学评估:来自前瞻性多中心观察队列的结果。
  • DOI:
    10.21203/rs.3.rs-3692289/v1
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Atreya,MihirR;Huang,Min;Moore,AndrewR;Zheng,Hong;Hasin-Brumshtein,Yehudit;Fitzgerald,JulieC;Weiss,ScottL;Cvijanovich,NatalieZ;Bigham,MichaelT;Jain,ParagN;Schwarz,AdamJ;Lutfi,Riad;Nowak,Jeffrey;Thomas,NealJ;Quasney,Mic
  • 通讯作者:
    Quasney,Mic
Development of a Pediatric Blood Pressure Percentile Tool for Clinical Decision Support.
  • DOI:
    10.1001/jamanetworkopen.2022.36918
  • 发表时间:
    2022-10-03
  • 期刊:
  • 影响因子:
    13.8
  • 作者:
    Martin, Blake;DeWitt, Peter E.;Albers, David;Bennett, Tellen D.
  • 通讯作者:
    Bennett, Tellen D.
Commentary: 'Critical illness subclasses: all roads lead to Rome'.
Patterns of Organ Dysfunction in Critically Ill Children Based on PODIUM Criteria.
  • DOI:
    10.1542/peds.2021-052888p
  • 发表时间:
    2022-01-01
  • 期刊:
  • 影响因子:
    8
  • 作者:
    Sanchez-Pinto, L. Nelson;Bembea, Melania M.;Farris, Reid Wd;Hartman, Mary E.;Odetola, Folafoluwa O.;Spaeder, Michael C.;Watson, R. Scott;Zimmerman, Jerry J.;Bennett, Tellen D.
  • 通讯作者:
    Bennett, Tellen D.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tellen Bennett其他文献

Tellen Bennett的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tellen Bennett', 18)}}的其他基金

Novel Pediatric Sepsis Criteria and Clinical Decision Support Tools
新型儿科败血症标准和临床决策支持工具
  • 批准号:
    10280004
  • 财政年份:
    2021
  • 资助金额:
    $ 63.36万
  • 项目类别:
Novel Pediatric Sepsis Criteria and Clinical Decision Support Tools
新型儿科败血症标准和临床决策支持工具
  • 批准号:
    10478249
  • 财政年份:
    2021
  • 资助金额:
    $ 63.36万
  • 项目类别:
Pediatric COVID-19 Dashboard and Clinical Phenotypes
儿科 COVID-19 仪表板和临床表型
  • 批准号:
    10658654
  • 财政年份:
    2021
  • 资助金额:
    $ 63.36万
  • 项目类别:
Archiving Common Data Element-Harmonized Pediatric Traumatic Brain Injury Data and Metadata
归档通用数据元素 - 协调的儿科创伤性脑损伤数据和元数据
  • 批准号:
    9789058
  • 财政年份:
    2018
  • 资助金额:
    $ 63.36万
  • 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
  • 批准号:
    8579363
  • 财政年份:
    2013
  • 资助金额:
    $ 63.36万
  • 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
  • 批准号:
    8695424
  • 财政年份:
    2013
  • 资助金额:
    $ 63.36万
  • 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
  • 批准号:
    9049521
  • 财政年份:
    2013
  • 资助金额:
    $ 63.36万
  • 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
  • 批准号:
    9263010
  • 财政年份:
    2013
  • 资助金额:
    $ 63.36万
  • 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
  • 批准号:
    8857351
  • 财政年份:
    2013
  • 资助金额:
    $ 63.36万
  • 项目类别:
Effectiveness of ICP Monitoring in Pediatric Traumatic Brain Injury
ICP 监测在小儿创伤性脑损伤中的有效性
  • 批准号:
    8847755
  • 财政年份:
    2013
  • 资助金额:
    $ 63.36万
  • 项目类别:

相似海外基金

Signature Research Project
签名研究项目
  • 批准号:
    10577120
  • 财政年份:
    2023
  • 资助金额:
    $ 63.36万
  • 项目类别:
Substance Use and Firearm Injuries among Medicaid-enrolled Youth
参加医疗补助的青少年的药物使用和枪伤
  • 批准号:
    10811094
  • 财政年份:
    2023
  • 资助金额:
    $ 63.36万
  • 项目类别:
NIDA Clinical Trials Network: New York Node - GY22 Integrating MOUD in Non-Medical Settings to Improve Treatment and Retention of Black/AA Persons
NIDA 临床试验网络:纽约节点 - GY22 在非医疗环境中整合 MOUD,以改善黑人/AA 人的治疗和保留
  • 批准号:
    10809985
  • 财政年份:
    2023
  • 资助金额:
    $ 63.36万
  • 项目类别:
Clinical Trials Network: Admin Supplement: Integrating MOUD with BUP in Non-medical Community Settings
临床试验网络:管理补充:在非医疗社区环境中将 MOUD 与 BUP 集成
  • 批准号:
    10801347
  • 财政年份:
    2023
  • 资助金额:
    $ 63.36万
  • 项目类别:
I-CARE: The Effectiveness of a Modular Digital Intervention to Reduce Suicidal Ideation and Emotional Distress during Pediatric Psychiatric Boarding
I-CARE:模块化数字干预对减少儿科精神科寄宿期间的自杀意念和情绪困扰的有效性
  • 批准号:
    10756733
  • 财政年份:
    2023
  • 资助金额:
    $ 63.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了